SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 4, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $254K total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading signal. Monitor for larger C-suite transactions or a material corporate event (e.g., earnings, pipeline update) that could provide context for any future insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.11
T+0 close · Aug 4, 2026 · via day close
Latest settled
+32.55%
T+60 · $10.75
Vs SPY
+32.61%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $8.11entry
  2. T+1 · 3mo ago −9.25%α −9.09% · $7.36
  3. T+5 · 3mo ago +4.69%α +4.33% · $8.49
  4. T+20 · 3mo ago +5.80%α +6.40% · $8.58
  5. T+60 · 19d ago +32.55%α +32.61% · $10.75
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two non-C-suite insiders at Xeris Biopharma sold a combined $254K in open-market transactions over a 7-day window. The total value represents just 0.018% of the company's $1.4B market cap, making this a routine and immaterial cluster with no predictive signal.

Key Financial Metrics

Direction
selling
Total Value
$253.8K
Insiders
2

Key Facts

  • Two insiders (Beth Hecht and Kevin McCulloch, both 'See Remarks') sold shares on August 3, 2026.
  • Total sale value: $253,793 (Hecht: $133,553; McCulloch: $120,240).
  • Sales represent ~0.018% of Xeris's $1.4B market cap, well below the 0.1% materiality threshold.
  • Both transactions were open-market sales; no 10b5-1 plan or regular pattern noted.

Financial Impact

Negligible, $254K in insider sales is less than 0.02% of market cap.

Risk Factors

  • Insider sales at this trivial level carry no informational content; no bearish read-through.
  • Larger insider sales or a cluster exceeding 0.5% of market cap would be a more meaningful signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1785901908217

US Market Status

Market Closed · Opens in 5h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026